[HTML][HTML] Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications

Z Ma, KY Yang, Y Huang, KO Lui - Journal of Molecular and Cellular …, 2022 - Elsevier
The global propagation of SARS-CoV-2 leads to an unprecedented public health
emergency. Despite that the lungs are the primary organ targeted by COVID-19, systemic …

Persistent endotheliopathy in the pathogenesis of long COVID syndrome

H Fogarty, L Townsend, H Morrin… - … of thrombosis and …, 2021 - Wiley Online Library
Background Persistent symptoms including breathlessness, fatigue, and decreased exercise
tolerance have been reported in patients after acute SARS‐CoV‐2 infection. The biological …

Platelet activation and thrombosis in COVID-19

T Iba, H Wada, JH Levy - Seminars in Thrombosis and …, 2023 - thieme-connect.com
Although thrombosis frequently occurs in infectious diseases, the coagulopathy associated
with COVID-19 has unique characteristics. Compared with bacterial sepsis, COVID-19 …

Sustained VWF‐ADAMTS‐13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction

H Fogarty, SE Ward, L Townsend… - … of Thrombosis and …, 2022 - Wiley Online Library
Background Prolonged recovery is common after acute SARS‐CoV‐2 infection; however,
the pathophysiological mechanisms underpinning Long COVID syndrome remain unknown …

Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement

M Sayyadi, S Hassani, M Shams, A Dorgalaleh - Annals of Hematology, 2023 - Springer
The coagulation, fibrinolytic, anticoagulation, and complement systems are in delicate
balance with the vessel wall endothelium ensuring appropriate hemostasis. Coagulopathy …

NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis

N Potere, E Garrad, Y Kanthi, M Di Nisio… - Cardiovascular …, 2023 - academic.oup.com
Immunothrombosis—immune-mediated activation of coagulation—is protective against
pathogens, but excessive immunothrombosis can result in pathological thrombosis and …

Pathophysiology of COVID-19: critical role of hemostasis

SA Andrade, DA de Souza, AL Torres… - Frontiers in cellular …, 2022 - frontiersin.org
The COVID-19 pandemic, caused by SARS-CoV-2, had its first cases identified in late 2019
and was considered a clinical pandemic in March 2020. In March 2022, more than 500 …

[HTML][HTML] Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration

SPS Dhami, S Patmore, C Comerford, CM Byrne… - Journal of Thrombosis …, 2022 - Elsevier
Background Breast cancer results in a three‐to four‐fold increased risk of venous
thromboembolism (VTE), which is associated with reduced patient survival. Despite this, the …

Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2–induced lung exudative vasculitis and predicts COVID-19 severity

C Iwamura, K Hirahara, M Kiuchi… - Proceedings of the …, 2022 - National Acad Sciences
The mortality of coronavirus disease 2019 (COVID-19) is strongly correlated with pulmonary
vascular pathology accompanied by severe acute respiratory syndrome coronavirus 2 …

Investigating the relationship between vitamin D and persistent symptoms following SARS-CoV-2 infection

L Townsend, AH Dyer, P McCluskey, K O'Brien… - Nutrients, 2021 - mdpi.com
The emergence of persistent symptoms following SARS-CoV-2 infection, known as long
COVID, is providing a new challenge to healthcare systems. The cardinal features are …